CEFEPIME STRAGEN 2 g, powder for solution for injection/for infusion bottle, 2 g
Active ingredients: Cefepime, Cefepime hydrochloride hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusionbottle, 2 gintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFEPIME STRAGEN 2 g, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 2 g
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68016662CIP73020930CIP133400930209301Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFÉPIMEpoudre | 2 g · un flacon | FT |
| DICHLORHYDRATE DE CÉFÉPIME MONOHYDRATÉpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.